Jiangsu Nanfang Medical Co., Ltd. (603880.SS)
CNY 4.96
(-1.39%)
CNY 4.96
(-1.39%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 418.05 Thousand CNY | -97.57% |
| 2022 | 17.22 Million CNY | 1085.19% |
| 2021 | 1.45 Million CNY | 0.0% |
| 2020 | - CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 55.65 Million CNY | 0.0% |
| 2024 Q1 | 272.63 Thousand CNY | 0.0% |
| 2024 Q3 | -7.22 Million CNY | -7.19% |
| 2023 FY | 418.05 Thousand CNY | -97.57% |
| 2023 Q1 | 17.47 Million CNY | 1.43% |
| 2023 Q3 | 7.48 Million CNY | -29.7% |
| 2023 Q4 | 418.05 Thousand CNY | -94.42% |
| 2023 Q2 | 10.65 Million CNY | -39.03% |
| 2022 Q3 | 1.5 Million CNY | 1.23% |
| 2022 Q2 | 1.48 Million CNY | 9.75% |
| 2022 Q1 | 1.35 Million CNY | -6.59% |
| 2022 FY | 17.22 Million CNY | 1085.19% |
| 2022 Q4 | 17.22 Million CNY | 1042.15% |
| 2021 Q3 | 1.00 CNY | 0.0% |
| 2021 Q1 | - CNY | 0.0% |
| 2021 Q2 | - CNY | 0.0% |
| 2021 FY | 1.45 Million CNY | 0.0% |
| 2021 Q4 | 1.45 Million CNY | 145335499.73% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2020 FY | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |